Humana Inc. $HUM Holdings Boosted by Armistice Capital LLC

Armistice Capital LLC boosted its position in shares of Humana Inc. (NYSE:HUM) by 39.6% during the 4th quarter, HoldingsChannel reports. The firm owned 71,697 shares of the insurance provider’s stock after buying an additional 20,338 shares during the quarter. Armistice Capital LLC’s holdings in Humana were worth $18,364,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HUM. Montag A & Associates Inc. boosted its stake in shares of Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after buying an additional 94 shares during the period. CoreCap Advisors LLC boosted its stake in shares of Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after buying an additional 37 shares during the period. Fideuram Asset Management Ireland dac acquired a new stake in shares of Humana during the 4th quarter valued at $27,000. Rosenberg Matthew Hamilton boosted its stake in shares of Humana by 136.0% during the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after buying an additional 68 shares during the period. Finally, Larson Financial Group LLC boosted its stake in shares of Humana by 114.1% during the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after buying an additional 81 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Stock Down 2.0%

HUM stock opened at $361.95 on Thursday. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $380.86. The company has a fifty day simple moving average of $279.36 and a 200 day simple moving average of $239.95. The firm has a market cap of $43.46 billion, a PE ratio of 38.71, a PEG ratio of 2.10 and a beta of 0.76.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. During the same quarter in the previous year, the business earned $11.58 EPS. Humana’s quarterly revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts anticipate that Humana Inc. will post 9.04 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.0%. Humana’s payout ratio is currently 37.86%.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on HUM shares. Seaport Research Partners lowered Humana to a “neutral” rating in a report on Wednesday, May 20th. Barclays lifted their price target on Humana from $180.00 to $344.00 and gave the company an “equal weight” rating in a report on Tuesday, May 26th. Weiss Ratings upgraded Humana from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, June 12th. Wolfe Research upgraded Humana from a “hold” rating to a “strong-buy” rating in a report on Thursday, June 4th. Finally, Mizuho lifted their price objective on shares of Humana from $335.00 to $390.00 and gave the company an “outperform” rating in a research note on Monday, June 8th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, sixteen have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, Humana presently has a consensus rating of “Hold” and an average price target of $291.35.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.